missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human CREB3L1 (aa 153-208) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (89%), Rat (89%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-144901 (PA5-144901. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
Transcription factor that acts during endoplasmic reticulum stress by activating unfolded protein response target genes. Specifically involved in ER-stress response in astrocytes in the central nervous system. May play a role in gliosis. In vitro, binds to box-B element, cAMP response element (CRE) and CRE-like sequences, and activates transcription through box-B element but not through CRE.
Specifications
Specifications
| Accession Number | Q96BA8 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 90993 |
| Name | Human CREB3L1 (aa 153-208) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | BBF-2 homolog; cAMP responsive element binding protein 3 like 1; cAMP responsive element binding protein 3-like 1; cAMP-responsive element-binding protein 3-like protein 1; CREB3L1; Cyclic AMP-responsive element-binding protein 3-like protein 1; OA-N; Oasis; Oasis N-terminal fragment; old astrocyte specifically induced substance; old astrocyte specifically-induced substance; Processed cyclic AMP-responsive element-binding protein 3-like protein 1; PSEC0238 |
| Common Name | CREB3L1 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction